ATOPIC DERMATITIS / ECZEMA

This study tested a cream called ARQ-151 to see if it safely reduces eczema symptoms in young children. Over 650 kids aged 2 to 5 with moderate to severe eczema applied the cream or a placebo once daily for 4 weeks. Doctors measured how much the children's skin cleared up and imp…

This study followed over 1,200 children (ages 2+) and adults with mild to moderate eczema for up to a year to check the long-term safety of a daily-use cream called roflumilast. Participants had already used the cream in earlier short-term studies. The main goal was to track any …

This study tested whether the drug tofacitinib is safe and effective for treating several common autoimmune skin conditions in adolescents and adults with Down syndrome. Researchers wanted to see if reducing overactive immune signaling could improve skin health, quality of life, …

This study tested whether managing eczema through an online team of doctors works as well as traditional in-person visits. 300 patients with eczema were randomly assigned to either use the online system or continue with regular office appointments for one year. Researchers compar…

This study tested the safety of a daily cream called roflumilast for treating eczema in infants. It involved 101 babies aged 3 months to under 2 years who used the cream for 4 weeks. The main goal was to check for any side effects or skin reactions from the treatment.

This study aimed to understand how the approved eczema medication dupilumab changes the immune environment and gene activity in the skin over time. Seventeen adults with moderate-to-severe eczema received dupilumab injections for a year. Researchers took small skin samples to ana…